Pharmacoeconomic profile of paclitaxel as a first-line treatment for patients with advanced ovarian carcinoma: A lifetime cost-effectiveness analysis [2]

Cancer

Volumn 79, Issue 11, 1997, Pages 2264-2266

  Messori, A ^a   Cecchi, M ^a   Becagli, P ^a   Trippoli, S ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

CANCER SURVIVAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; OVARY CARCINOMA; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; STATISTICAL MODEL;

EID: 0030926806     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970701)79:11<2264::AID-CNCR29>3.0.CO;2-S     Document Type: Letter

References (7)